Related Experiment Video
Updated: Jul 1, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Pulmonary siderosis complicated with severe mycoplasma pneumoniae pneumonia: A case report
Zhen Huang1,2, Tao Cheng1, Guangwen Chen1
1Department of Radiology, Chengdu Second People's Hospital, Chengdu, Sichuan, China.
Abstract:
Idiopathic pulmonary hemosiderosis (IPH) is a rare and fatal lung disease. Mycoplasma pneumoniae pneumonia (MPP) is the main community-acquired pneumonia among children aged 5 and above in China. We report the following case of IPH complicated with severe mycoplasma pneumoniae pneumonia(SMPP). An 8-year-old boy with cough and fever was diagnosed with IPH for 3 years and his chest computed tomography showed bilateral bronchopneumonia, lobular consolidation and subpleural interstitial fibrosis. As far as we know, IPH related to SMPP is rarely reported. In the high incidence period of MPP, clinicians and radiologists should be alert to the co-occurrence of IPH and SMPP.
Insights
Idiopathic pulmonary hemosiderosis (IPH) with severe Mycoplasma pneumoniae pneumonia (SMPP) is a rare but serious condition. Early recognition of this IPH and SMPP co-occurrence is crucial for timely diagnosis and treatment in children.
Area of Science:
- Pulmonology
- Pediatrics
- Infectious Diseases
Background:
- Idiopathic pulmonary hemosiderosis (IPH) is a rare, often fatal lung disease.
- Mycoplasma pneumoniae pneumonia (MPP) is a common community-acquired pneumonia in children over five in China.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

